People

Our Team

AI Therapeutics boasts a highly accomplished team with executional expertise across all stages of clinical development.

Leadership
Brigette Roberts, M.D.
Acting CEO
Scott B Kozak
Chief Business Development Officer
Peter Young, Ph.D.
Chief Scientific Officer
Keith Fandrick, Ph.D.
Chief Development Officer
Joan Edwards
Chief Quality Assurance Officer
Brad Parry, Ph.D.
Head of AI
Board of Directors
Jonathan Rothberg, Ph.D.
George Rehm
Management
No items found.
Scientific Advisory Board
Lawrence Melvin, Ph.D.
Murat Gunel, M.D.
Chair
Tian Xu, Ph.D.